<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine
Image Overlay - MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

The U.K.'s Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for emergency use to Pfizer and BioNTech for their COVID-19 mRNA vaccine BNT162b2 . This is the first Emergency Use Authorization following a worldwide phase III trial of a vaccine to help fight the pandemic. Like the global population, Yourway has closely followed COVID-19 vaccine trials and is excited about the beginnings of a wider rollout of the vaccine.

Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?